Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Key Movement
    • Eli Lilly appoints...

    Eli Lilly appoints Luca Visini as MD of India operations

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-15T10:00:13+05:30  |  Updated On 15 Feb 2018 10:00 AM IST
    Eli Lilly appoints Luca Visini as MD of India operations

    New Delhi: US pharma major Eli Lilly and Company said it has appointed Luca Visini as managing director of its Indian subsidiary with effect from February 1, 2018.


    Visini replaces Edgard Olaizola, who headed Lilly India operations from September 2013 to January 2018, and will now be moving internally to a new role.


    Visini joined Lilly in 2004 and held several strategic leadership roles in various functional departments out of Lilly headquarters in Indianapolis, the USA, and Europe.


    From 2011 to 2014, he was the country manager for Lilly Romania.


    Commenting on the appointment, Visini said: "I am taking the lead of Lilly India in a year that marks Lilly's 25-year presence in India, and that will witness the launch of several innovative medications which will help answer unmet needs."


    Lilly has a strong heritage and experience in the research, development, and management of chronic diseases such as cancer and diabetes and the company is determined to engage with all stakeholders in the healthcare field in India to help people live longer healthier and more active lives, he added.


    In 1993, Eli Lilly and Company established its wholly- owned subsidiary Eli Lilly and Company (India) Pvt Ltd, headquartered in Gurgaon.


    Since then, Lilly India has expanded its operations considerably in the country.

    appointmentcancerdiabetesEdgard OlaizolaEli LillyEli Lilly and Company Pvt LtdHealthcareLuca VisiniManaging director
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok